Dongkwang Chemical

Dongkwang Pharmaceutical is a South Korean pharmaceutical company established in 1952, originally under the name Dongkwang Chemical. The company specializes in the development, manufacturing, and marketing of a broad range of ethical (ETC) and over-the-counter (OTC) medicines. Its core strengths lie in injectable drugs, antibiotics, and treatments for musculoskeletal, gastrointestinal, and cardiovascular conditions. Dongkwang operates a KGMP-certified production facility in Pyeongtaek and a research institute in Seoul focused on incrementally modified drugs (IMDs). The company is a well-established player in the Korean domestic market, known for its high-quality generic formulations and specialized hospital products. It continues to expand its portfolio through internal R&D and strategic partnerships within the Asian market.